100%/100% is incredible - and I wouldn’t be surprised to see this come to market very quickly.
I had a client who had a delayed prostrate cancer diagnosis and due to delay it metastasised and he died within approx 12 months. When looking deeply into the research on PSA - what it showed was a) it was really only a feeder into surgical biopsy to definite diagnosis but by monitoring the ‘rises’ over consecutive years it could give an earlier indicator, still not precise. what i see happening with B2M - is yearly screening tests for at risk populations & any year on year rises in the levels present for ‘early stage’ will be able to be determined by algorithmic analysis as to what specific % of rise determines referral for surgical biopsy.
huge implications for the treatment of cancer
- Forums
- ASX - By Stock
- IIQ
- Ann: Outstanding SubB2M Ovarian Cancer Test Data
Ann: Outstanding SubB2M Ovarian Cancer Test Data, page-480
-
- There are more pages in this discussion • 53 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
|
|||||
Last
59.5¢ |
Change
0.030(5.31%) |
Mkt cap ! $66.16M |
Open | High | Low | Value | Volume |
57.0¢ | 60.5¢ | 57.0¢ | $21.86K | 36.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1009 | 58.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
60.0¢ | 11650 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1009 | 0.585 |
1 | 1724 | 0.580 |
2 | 1670 | 0.575 |
2 | 34035 | 0.570 |
1 | 37 | 0.565 |
Price($) | Vol. | No. |
---|---|---|
0.600 | 11650 | 6 |
0.605 | 1447 | 2 |
0.610 | 5000 | 2 |
0.620 | 16167 | 2 |
0.625 | 1584 | 1 |
Last trade - 12.34pm 10/07/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online